Covid19, Myocardial Infarction, Myocarditis, Non Ischemic Myocardial Injury, Troponin Elevation
Conditions
Brief summary
Myocardial injury, as assessed by elevation of cardiac troponins (Tnc), is frequent among patients with COVID-19. Although rare autopsy cases reported COVID-19 related myocardial inflammation, the origin of Tnc elevation is unknown to date. Several cardiac causes, such as myocarditis, non-ischemic myocardial injury (NIMI), or myocardial infarction (MI) may lead to Tnc kinetic. Our work will test the hypothesis that during SARS-Cov2 infection, the elevation of cardiac biomarkers could be linked to the occurrence of myocarditis.
Interventions
BIOLOGICALBiological data
Biological data
OTHERClinical data
Clinical data
Sponsors
Centre Hospitalier Universitaire Dijon
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* COVID-19 positive patient hospitalized \< 72 h after symptoms onset with troponin assessement.
Exclusion criteria
* patients hospitalized \> 72h after symptom onset
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| characterize the myocardial damage associated with CoV-2 SARS infection | Through study completion, an average of 2 years | Myocardtitis diagnosis in patients COVID+ and troponin+ |
Countries
France
Outcome results
None listed